GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Other Long-Term Liabilities

Annexin Pharmaceuticals AB (OSTO:ANNX) Other Long-Term Liabilities : kr0.00 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Other Long-Term Liabilities?

Annexin Pharmaceuticals AB's other long-term liabilities for the quarter that ended in Sep. 2024 was kr0.00 Mil.

Annexin Pharmaceuticals AB's quarterly other long-term liabilities declined from Mar. 2024 (kr0.00 Mil) to Jun. 2024 (kr0.00 Mil) but then stayed the same from Jun. 2024 (kr0.00 Mil) to Sep. 2024 (kr0.00 Mil).

Annexin Pharmaceuticals AB Other Long-Term Liabilities Historical Data

The historical data trend for Annexin Pharmaceuticals AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annexin Pharmaceuticals AB Other Long-Term Liabilities Chart

Annexin Pharmaceuticals AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only - - - - -

Annexin Pharmaceuticals AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Annexin Pharmaceuticals AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Annexin Pharmaceuticals AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Annexin Pharmaceuticals AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Annexin Pharmaceuticals AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Other Long-Term Liabilities
Comparable Companies
OSTO:BIOSGN XSAT:RESP NGM:COEGIN XSAT:ABERA OSTO:COMBI OSTO:EXPRS2 OSTO:SCOL OSTO:LPGO XSAT:DEX XSAT:CHOSA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Kammakargatan 48, Stockholm, SWE, 111 60
Website
https://www.annexinpharma.com
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.